Market Cap: $866.92M
KI
Kura Oncology, Inc.
KURA
NASDAQUSD
Market Cap: $866.92M
Kura Oncology Reports Encouraging Q4 Earnings and Strategic Developments Kura Oncology recently releases its fourth-quarter earnings results, showing promising advancements in both its financial perfo…
Kura Oncology Charts Progress in Cancer Therapeutics with Upcoming Earnings Report As Kura Oncology approaches its quarterly earnings report scheduled for March 5, 2026, the company finds itself at a…
Kura Oncology Advances Innovative Cancer Therapies Amid Positive Earnings Insights Kura Oncology, a biopharmaceutical company focused on developing innovative cancer therapies, prepares to release its…
### Kura Oncology: Advancements in Immunotherapy for Blood Cancers Kura Oncology is positioned at the forefront of cancer treatment advancements, particularly in the realm of immunotherapy. The compan…
Innovative Immunotherapy Development in Blood Cancer Treatment GT Biopharma, Inc. is making significant progress in the realm of cancer treatment with its immunotherapy drug, GTB-3650. The company rec…
GT Biopharma Advances Immunotherapy in Blood Cancer Treatment GT Biopharma, Inc. is making significant headway in the fight against blood cancers with its innovative immunotherapy drug, GTB-3650. The…
FDA Grants Full Approval to Kura Oncology’s Komzifti for AML Treatment In a significant advancement for cancer treatment, Kura Oncology Inc., in collaboration with Kyowa Kirin Co., Ltd., secures full…
Kura Oncology Celebrates FDA Approval for Komzifti: A New Hope in AML Treatment Kura Oncology Inc., in collaboration with Kyowa Kirin Co., Ltd., achieves a significant milestone with the full approval…
Kura Oncology Focuses on Advancing Cancer Treatments Amidst Financial Landscape Kura Oncology, a clinical-stage biopharmaceutical company, is at the forefront of developing innovative therapies for ca…
Kura Oncology's Strategic Focus on Oncology Innovation Amid Industry Earnings Reports Kura Oncology stands out in the biopharmaceutical landscape, actively advancing its commitment to developing trans…
### Kura Oncology: Advancing Cancer Therapies through Strategic Collaborations Kura Oncology, Inc. is making significant strides in its mission to develop innovative cancer therapies, a commitment und…
Kura Oncology Strengthens Position in Oncology with Key Milestone Payment Kura Oncology, Inc. solidifies its standing in the competitive biotechnology sector with the announcement of a $30 million mil…
Kura Oncology: Leading the Charge in Biotech Innovation Kura Oncology stands at the forefront of the biotechnology sector, harnessing the potential of innovative therapies to address unmet medical nee…
Biotechnology's Resilience: A Focus on Innovation Amid Market Volatility In the current market landscape, biotechnology companies, particularly Kura Oncology, are gaining traction as investors seek st…
Shifting Focus: The Biotechnology Sector Gains Momentum Amid Market Volatility In recent days, observers note a significant shift in investor interest towards biotechnology companies, with a particula…
Kura Oncology: Navigating Challenges in the Biopharmaceutical Landscape Kura Oncology is currently positioned at a critical juncture in the biopharmaceutical sector, where the interplay of innovation…
Kura Oncology's Commitment to Advancing Cancer Treatments Kura Oncology continues to make significant strides in the field of oncology with its innovative approach to developing targeted therapies for…
Kura Sushi Sparks Joy with Peanuts Collaboration Kura Sushi USA, Inc. embarks on a nostalgic journey as it announces a limited-time promotion featuring a collaboration with the beloved Peanuts franchi…
Kura Sushi Unveils Peanuts Collaboration to Enrich Dining Experience Kura Sushi USA, Inc. announces an exciting new collaboration with the Peanuts franchise, launching the Peanuts x Kura Sushi Bikkura…